Enhancer of Zeste 2 (EZH2), the enzymatic component of PRC2 that methylates of lysine 27 at histone H3, is often overexpressed in prostate cancer (Koh et al., 2011; Bracken, 2003; Varambally et al., 2002). This evidence concerns the gene EZH2 and Familial prostate cancer.